Central Sleep Apnea with Cheyne-Stokes Respiration in Heart Failure
A 70-year-old man with HFrEF (LVEF 30%), NYHA class III symptoms, and atrial fibrillation is admitted with decompensated heart failure. He reports orthopnea and paroxysmal nocturnal dyspnea. Overnight oximetry shows recurrent cyclical desaturations with a crescendo-decrescendo pattern and a central apnea index of 28/h on a portable study. He is on guideline-directed medical therapy, but diuresis is still being optimized. He asks whether he needs CPAP right away.
1. How would you classify his sleep-disordered breathing, and why is the timing of treatment important?
Read the worked answer
The cyclical crescendo-decrescendo pattern with central apneas in a patient with HFrEF and AF is most consistent with central sleep apnea with Cheyne-Stokes respiration, though obstructive events must be excluded on a full study. Treatment timing matters because central apnea severity often improves with optimization of volume status and heart failure therapy; treating during acute decompensation can confound interpretation and lead to inappropriate intervention. The priority is decongestion and guideline-directed medical therapy, with reassessment once euvolemic; a full in-laboratory study with titration is preferable to a portable study for characterization.
2. What are the treatment options and their caveats in this population?
Read the worked answer
Options include optimization of heart failure therapy, oxygen in selected patients, adaptive servo-ventilation (ASV), and CPAP if there is coexisting OSA. A key caveat is that ASV was associated with increased mortality in a landmark trial of patients with HFrEF and predominantly central sleep apnea (SERVE-HF), so ASV is generally avoided in symptomatic HFrEF with LVEF ≤45%. CPAP is reasonable if obstructive events predominate or coexist. Treatment decisions should be individualized and coordinated with heart failure specialists, with repeat testing after medical optimization.
3. What would you tell him about the relationship between his sleep-disordered breathing and his atrial fibrillation and prognosis?
Read the worked answer
Explain that sleep-disordered breathing is common in heart failure and AF and is associated with worse outcomes and arrhythmia burden, but that treating central apnea has not consistently been shown to improve mortality in HFrEF, and one mode of therapy (ASV) was harmful in that population. The most reliable gains come from optimizing heart failure therapy and volume status. He should be reassessed after decongestion, and any device therapy should be chosen with his cardiologist and confirmed with follow-up testing.